Managing Your Network: Are Your Specialty Pharmacies Meeting Program Expectations?
Throughout our work with pharmaceutical manufacturers, we’ve seen varying levels of quality within programs regarding specialty pharmacies providing patient care, engaging with prescribers, and working with payers to ensure the product gets into the hands of those who need it. Management of external partners is an essential aspect of any program.
Watch Archbow Consulting’s Gabrielle Brennan and Mike Poland lead a webinar on the four essential strategies manufacturers need to transform their Specialty Pharmacy networks into efficient powerhouses to enhance patient care, foster innovative HCP relationships, build robust payer partnerships, and ensure product accessibility.
In this must-watch webinar, Archbow Consulting experts will reveal four critical best practices for Specialty Pharmacy performance assessments. Discover how manufacturers can effectively monitor, track, and pinpoint potential issues before they escalate into major problems. Tailored for pharma and biotech professionals, this presentation will empower your Specialty Pharmacy network by:
-
- Defining an effective SP performance assessment
- Outlining the four essential best practices for consistent and impactful performance evaluations
- Sharing a compelling real-world case study that showcases success
- Providing a timeline for performance assessments, from product launch to ongoing optimization
Don’t miss this opportunity to elevate your Specialty Pharmacy network’s efficiency and effectiveness!
For additional insights on this topic, you may also enjoy the following:
Medical Benefit Patient Support Programs: The Questions That Shape the Right Model
Explore seven key questions for designing medical benefit patient support programs that align with patient needs, provider workflows, and real-world access and reimbursement challenges.
Mastering 3PL Economics for Manufacturers
Discover how specialized 3PL cost analysis helps manufacturers identify pricing discrepancies and negotiate with confidence.
Preparing for the FDA’s 12-Digit NDC Transition
Manufacturers should begin planning early to assess impacts, align stakeholders, update affected processes, and allow sufficient time for testing and implementation before the March 7, 2033 deadline.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|


